Evidence map›Paper›PMID 32907486›Full record

ArticleCirculation research2020

Exercise Regulates MicroRNAs to Preserve Coronary and Cardiac Function in the Diabetic Heart.

Jason Kar-Sheng Lew, James T Pearson, Eugene Saw, Hirotsugu Tsuchimochi, Melanie Wei, Nilanjan Ghosh, Cheng-Kun Du, Dong-Yun Zhan, Meihua Jin, Keiji Umetani and 3 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. miR-126: a bridge between cancer and exercise.Cancer cell international · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Jason Kar-Sheng LewDepartment of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
James T PearsonDepartment of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (J.T.P., H.T., C.-K.D., D.-Y.Z., M.-H.K.).
Eugene SawDepartment of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
Hirotsugu TsuchimochiDepartment of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (J.T.P., H.T., C.-K.D., D.-Y.Z., M.-H.K.).
Melanie WeiDepartment of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
Nilanjan GhoshDepartment of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
Cheng-Kun DuDepartment of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (J.T.P., H.T., C.-K.D., D.-Y.Z., M.-H.K.).
Dong-Yun ZhanDepartment of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (J.T.P., H.T., C.-K.D., D.-Y.Z., M.-H.K.).
Meihua JinDepartment of Advanced Medical Research for Pulmonary Hypertension, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (M.S., M.J.).
Keiji UmetaniJapan Synchrotron Radiation Research Institute, Hyogo, Japan (K.U.).
Mikiyasu ShiraiDepartment of Advanced Medical Research for Pulmonary Hypertension, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan (M.S., M.J.).
Rajesh Katare *Department of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
Daryl O Schwenke *Department of Physiology, School of Biomedical Sciences, HeartOtago, University of Otago, Dunedin, New Zealand (J.K.-S.L., E.S., M.W., N.G., R.K., D.O.S.).
University of Otago · NZNational Cerebral and Cardiovascular Center · JPDiscovery Institute · USJapan Synchrotron Radiation Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleDiabetic heart disease (DHD) is a debilitating manifestation of type 2 diabetes mellitus. Exercise has been proposed as a potential therapy for DHD, although the effectiveness of exercise in preventing or reversing the progression of DHD remains controversial. Cardiac function is critically dependent on the preservation of coronary vascular function.

objectiveWe aimed to elucidate the effectiveness and mechanisms by which exercise facilitates coronary and cardiac-protection during the onset and progression of DHD. METHODS AND

resultsDiabetic db/db and nondiabetic mice, with or without underlying cardiac dysfunction (16 and 8 weeks old, respectively) were subjected to either moderate-intensity exercise or high-intensity exercise for 8 weeks. Subsequently, synchrotron microangiography, immunohistochemistry, Western blot, and real-time polymerase chain reaction were used to assess time-dependent changes in cardiac and coronary structure and function associated with diabetes mellitus and exercise and determine whether these changes reflect the observed changes in cardiac-enriched and vascular-enriched microRNAs (miRNAs). We show that, if exercise is initiated from 8 weeks of age, both moderate-intensity exercise and high-intensity exercise prevented the onset of coronary and cardiac dysfunction, apoptosis, fibrosis, microvascular rarefaction, and disruption of miRNA signaling, as seen in the nonexercised diabetic mice. Conversely, the cardiovascular benefits of moderate-intensity exercise were absent if the exercise was initiated after the diabetic mice had already established cardiac dysfunction (ie, from 16 weeks of age). The experimental silencing or upregulation of miRNA-126 activity suggests the mechanism underpinning the cardiovascular benefits of exercise were mediated, at least in part, through tissue-specific miRNAs.

conclusionsOur findings provide the first experimental evidence for the critical importance of early exercise intervention in ameliorating the onset and progression of DHD. Our results also suggest that the beneficial effects of exercise are mediated through the normalization of cardiovascular-enriched miRNAs, which are dysregulated in DHD.

Indexed as

Exercise TherapyPhysical Conditioning, AnimalAnimalsDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDisease Models, AnimalFemaleFibrosisGene Expression RegulationMaleMiceMicroRNAsMyocardiumRunningSignal TransductionTime FactorsMicroRNAsMIRN126 microRNA, mouseangiographydiabetes mellitusexerciseheart diseasemicroRNAs

Identifiers

PMID32907486
OpenAlexW3084570322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.